InnoCare tshaj tawm txog kev ua tiav ntawm Kev Sau Npe Neeg Mob hauv Phase II Clinical Trial ntawm ICP-488 rau Kev Kho Mob Psoriasis

May 17, 2024 Tso lus

InnoCare Pharma (HKEX: 09969; SSE: 688428), ib lub tuam txhab biopharmaceutical tseem ceeb rau kev kho mob qog noj ntshav thiab kab mob autoimmune, hnub no tshaj tawm txog kev ua tiav ntawm tus neeg mob rau npe rau theem II kev soj ntsuam ntawm ICP-488, TYK2 ( tyrosine kinase 2) JH2 allosteric inhibitor, rau kev kho mob psoriasis.

Qhov no yog ntau qhov chaw, randomized, ob-dig muag, placebo-tswj theem II kev tshawb fawb soj ntsuam tsom rau kev ntsuas kev ua tau zoo, kev nyab xeeb, PK thiab PD cov yam ntxwv ntawm ICP-488 hauv Suav cov neeg laus uas muaj mob nruab nrab mus rau mob hnyav plaque psoriasis. Tag nrho ntawm 129 tus neeg mob tau tso npe rau hauv txoj kev tshawb no. Cov neeg mob tau muab tso rau ib qho ntawm peb pawg kho mob hauv qhov sib piv 1: 1: 1, ib pawg 6mg ib zaug ib hnub, ib pawg 9mg ib zaug ib hnub, thiab pab pawg placebo, rau 12 lub lis piam sib law liag ntawm kev kho mob.

ICP-488 yog qhov ncauj, muaj zog thiab xaiv TYK2 allosteric inhibitor. Los ntawm kev khi lub npe JH2, ICP-488 thaiv cov teeb liab hloov ntawm IL-23, IL-12, hom 1 IFN thiab lwm yam inflammatory cytokine, yog li inhibiting cov txheej txheem pathological ntawm autoimmune thiab inflammatory kab mob. ICP-488 tau ua kom pom kev ua tau zoo thiab kev nyab xeeb nyob rau theem kuv kawm txog kev kho cov neeg mob psoriasis.

Dr. Jasmine Cui, Co-founder, Chairwoman thiab CEO ntawm InnoCare tau hais tias, "Psoriasis xav tau kev tswj xyuas mus sij hawm ntev, thiab tseem muaj qhov xav tau tseem ceeb rau cov tshuaj tshiab, tshwj xeeb tshaj yog cov tshuaj noj hauv qhov ncauj hauv nws txoj kev kho mob. Peb zoo siab heev los pom. Kev ua tiav ntawm cov neeg mob nkag rau hauv theem II kev sim tshuaj rau kev kho mob psoriasis nrog ICP-488 Peb tseem mob siab rau kev mob siab rau kev txhim kho kev kho mob ntawm qhov kev cog lus no, nrog lub hom phiaj ntawm kev muab kev kho mob zoo dua rau cov neeg mob psoriasis. sai li sai tau.

Cov ntaub ntawv tsis ntev los no qhia tias kwv yees li xya lab tus tib neeg hauv Suav teb tam sim no nyob nrog psoriasis1, thiab tus lej no tau nce2. Cov kev xaiv kho mob uas twb muaj lawm tsis hais txog qhov xav tau ntawm cov neeg cuam tshuam los ntawm tus mob no, qhia txog qhov sib txawv tseem ceeb hauv cov kev kho mob uas muaj. Muaj kev thov tshwj xeeb rau cov tshuaj tshiab, qhov ncauj. Ntau tus neeg mob, tshwj xeeb tshaj yog cov uas muaj mob hnyav-rau- mob psoriasis, txuas ntxiv mus tsis tu ncua lossis tseem tsis tau kho tag nrho.3.

1 Kev Tshawb Fawb Txog Kab Mob Psoriasis

2 2021. Kev nce qib hauv Epidemiological Investigation of Psoriasis, Phau ntawv Journal of Diagnostics Concepts & Practice. 2021.

3 Suav Cov Lus Qhia rau Kev Ntsuas thiab Kev Kho Mob Psoriasis (2018). Suav Journal of Dermatology. 2019. Kev tshawb fawb txog qhov xwm txheej ntawm Psoriasis Kev Noj Qab Haus Huv hauv Suav teb raws li Lub Ntiaj Teb Saib Xyuas Txoj Haujlwm ntawm Psoriasis thiab Kev Sib Raug Zoo ntawm Psoriasis thiab Obesity thiab Ntshav Qab Zib Hom II. 2020